FDA Accepts Supplement for Nizoral Anti-Dandruff Application
The FDA has accepted a supplemental application for Nizoral Anti-Dandruff, containing ketoconazole.
Therapeutic Area
Therapeutic area intelligence for Anti-fungal with 2 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.